repurposed imipramine (Ennaid Therapeutics)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namerepurposed imipramine (Ennaid Therapeutics)
Drug Alias NameImipramine (Ennaid Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFascin modulators
TargetsFascin
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesEurope +[5
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesEnnaid Therapeutics LLC
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A